C
MDT icon

Cerebellum’s Medtronic MDT Stock Holding History

Cerebellum’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,580
Closed -$128K – 505
2020
Q2 		$128K Buy
+1,580
New +$152K 0.09% 171
2019
Q4 		$280K Sell
2,469
-1,556
-39% -$171K 0.15% 346
2019
Q3 		$437K Buy
4,025
+335
+9% +$35K 0.28% 189
2019
Q2 		$359K Buy
3,690
+26
+0.7% +$2.37K 0.29% 57
2019
Q1 		$334K Buy
3,664
+1,729
+89% +$155K 0.29% 113
2018
Q4 		$176K Buy
1,935
+16
+0.8% +$1.5K 0.12% 317
2018
Q3 		$189K Sell
1,919
-199
-9% -$18.4K 0.3% 61
2018
Q2 		$181K Sell
2,118
-262
-11% -$21.9K 0.3% 48
2018
Q1 		$191K Buy
2,380
+800
+51% +$66K 0.24% 95
2017
Q4 		$128K Buy
+1,580
New +$127K 0.09% 171

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Cerebellum's MDT Position: Q3 2020 in Review

Cerebellum sold out of Medtronic (MDT) in Q3 2020, closing a stake of 1,580 shares — an estimated $128K sold.

Cerebellum first reported a position in MDT in Q4 2017 and held it in 10 quarters. The position peaked at $437K in Q3 2019. 1,810 funds tracked by Wall St. Rank hold MDT as of Q3 2020.

  • Cerebellum reported no remaining Medtronic position as of Q3 2020 after selling out during the quarter.
  • Cerebellum sold 1,580 Medtronic shares in Q3 2020, an estimated $128K.
  • Cerebellum first reported a position in Medtronic in Q4 2017 and held it in 10 quarters.
  • Cerebellum's Medtronic position peaked at $437K in Q3 2019.
  • 1,810 funds tracked by Wall St. Rank held Medtronic as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.